Publication | Open Access
Oncogenic PIK3CA recruits myeloid‐derived suppressor cells to shape the immunosuppressive tumour microenvironment in luminal breast cancer through the 5‐lipoxygenase‐dependent arachidonic acid pathway
22
Citations
34
References
2023
Year
The results emphasize that PIK3CA<sup>mut</sup> can induce immune evasion by recruiting MDSCs through the 5-LOX-dependent AA pathway, and combination targeted therapy with ICB may provide a promising treatment option for refractory advanced LBC patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1